Boehringer Ingelheim India has entered into a strategic partnership with Vvaan Lifesciences Pvt Ltd to distribute its pet parasiticide portfolio in Tier 2 cities of the country. The collaboration, an initiative under Boehringer Ingelheim India’s animal health accelerated growth plan, marks a significant step in expanding the company’s reach and enhancing customer value in the animal health sector. India’s pet health market is currently worth around €115 million ($129 million, or Rs1,078 crore). According to...